Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar
Authors:
- Htin Lin AungHAHtin Lin Aung
- Wint Wint NyuntWNWint Wint Nyunt
- Yang FongYFYang Fong
- Patrick J. BiggsPBPatrick J. Biggs
- Richard C. WinkworthRWRichard C. Winkworth
- Peter J. LockhartPLPeter J. Lockhart
- Tsin Wen YeoTYTsin Wen Yeo
- Philip C. HillPHPhilip C. Hill
- Gregory M. CookGCGregory M. Cook
- Si Thu AungSASi Thu Aung
Open Access
- 1 November 2021
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 27 (11) , 2847-2855
Abstract
Multidrug resistance is a major threat to global elimination of tuberculosis (TB). We performed phenotypic drug-susceptibility testing and whole-genome sequencing for 309 isolates from 342 consecutive patients who were given a diagnosis of TB in Yangon, Myanmar, during July 2016‒June 2018. We identified isolates by using the GeneXpert platform to evaluate drug-resistance profiles. A total of 191 (62%) of 309 isolates had rifampin resistance; 168 (88%) of these rifampin-resistant isolates were not genomically related, indicating the repeated emergence of resistance in the population, rather than extensive local transmission. We did not detect resistance mutations to new oral drugs, including bedaquiline and pretomanid. The current GeneXpert MTB/RIF system needs to be modified by using the newly launched Xpert MTB/XDR cartridge or line-probe assay. Introducing new oral drugs to replace those currently used in treatment regimens for multidrug-resistant TB will also be useful for treating TB in Myanmar.Keywords
This publication has 27 references indexed in Scilit:
- Drug-resistant tuberculosis among previously treated patients in Yangon, MyanmarInternational Journal of Mycobacteriology, 2016
- Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from MyanmarJournal of Global Antimicrobial Resistance, 2016
- Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective studyThe Lancet Respiratory Medicine, 2016
- Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort studyThe Lancet Infectious Diseases, 2015
- Rapid determination of anti-tuberculosis drug resistance from whole-genome sequencesGenome Medicine, 2015
- Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineageNature Genetics, 2015
- Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistanceNature Genetics, 2013
- Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational studyThe Lancet Infectious Diseases, 2013
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic treesBioinformatics, 2004